* Tearlab Corp says it has elected to pursue initial U.S. FDA clearance of a test card measuring a single inflammatory biomarker, MMP-9, in combination with co's osmolarity test * Tearlab - elected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results